Cataract Surgery

>

Latest News

VivaVision Biotech reports positive Phase 2 trial results of VVN461 for postoperative inflammation treatment following cataract surgery
VivaVision Biotech reports positive Phase 2 trial results of VVN461 for postoperative inflammation treatment following cataract surgery

December 5th 2024

According to the company, VVN461, a non-steroidal dual JAK1/TYK2 immunomodulator, achieved its primary endpoint, demonstrating statistical and clinical efficacy compared to vehicle in treating post-operative inflammation following cataract surgery.

Melt Pharmaceuticals reports positive Phase 3 topline efficacy results for MELT-300
Melt Pharmaceuticals reports positive Phase 3 topline efficacy results for MELT-300

November 20th 2024

Mazava Project shines light on blindness in Madagascar
Mazava Project shines light on blindness in Madagascar

November 16th 2024

HelpMeSee launches global effort to combat cataract blindness and empower women in low-income countries
HelpMeSee launches global effort to combat cataract blindness and empower women in low-income countries

November 14th 2024

HelpMeSee teaming up with Empowered with Meg Ryan to highlight solutions for global cataract blindness crisis in new episode
HelpMeSee teaming up with Empowered with Meg Ryan to highlight solutions for global cataract blindness crisis in new episode

November 14th 2024

Video Interviews
Podcasts
EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
EyePod: Transforming the MIGS pipeline into clinical practice
EYEPOD: Michael Rivers, MD, discusses the impact of Aetna's new policy requiring prior authorization for cataract surgery on ophthalmologists, their workflow, and patients.

More News

© 2024 MJH Life Sciences

All rights reserved.